Not available
Quote | Fibrocell Science Inc. (NASDAQ:FCSC)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $3.00 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 01/16/2020 04:52:12 pm |
News | Fibrocell Science Inc. (NASDAQ:FCSC)
RenovaCare ( OTCPK:RCAR +0.8% ) announces that its SkinGun , a patented device for spraying self-donated stem cells for the regeneration of skin and other organs/tissues, is being used in a preclinical study at King's College London to apply gene-supplemented cells (gene therapy) for ac...
Merger activity decreased with four new deals announced and two deals closing. Deal Statistics: New Deals: The acquisition of Diplomat Pharmacy (DPLO) by OptumRx for $300 million or $4.00 per share in cash. The acquisition of Synthorx (THOR) by Sanofi (SNY) for $2.35 billio...
Message Board Posts | Fibrocell Science Inc. (NASDAQ:FCSC)
Subject | By | Source | When |
---|---|---|---|
News: $FCSC Due to Rising Prevalence of Cancer | whytestocks | investorshub | 09/16/2019 12:40:20 PM |
.01 | CarlCarlMcB | investorshub | 07/05/2019 5:09:44 PM |
News: $FCSC Fibrocell to Present at BIO International | whytestocks | investorshub | 05/30/2019 12:40:39 PM |
News: $FCSC Fibrocell Receives FDA Regenerative Medicine Advanced | whytestocks | investorshub | 05/29/2019 3:30:38 PM |
GREEN | beambe | investorshub | 04/26/2019 8:00:37 PM |
News, Short Squeeze, Breakout and More Instantly...
Fibrocell Science Inc. Company Name:
FCSC Stock Symbol:
NASDAQ Market:
PARSIPPANY, N.J. , Sept. 12, 2019 /PRNewswire/ -- Castle Creek Pharmaceutical Holdings, Inc. ("CCP Holdings") today announced it has reached an agreement to acquire Fibrocell Science, Inc. (Nasdaq: FCSC), a cell and gene therapy company focused on transformational autologous cell-bas...
- Total consideration of $ 63.3 million, including repayment of debt and other financial instruments - - Acquisition expected to close in the fourth quarter of 2019 - - Further strengthens Castle Creek Pharmaceuticals as a leader in dermatology - EXTON, Pa., Sept. 12, 2019 (GL...
- Company to Host Conference Call and Webcast on Thursday, August 15 at 8:30 a.m. EDT - EXTON, Pa., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (Nasdaq: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissu...